Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- ORIONIndependent statistical analysis of EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ORION-1Independent statistical analysis of Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ORION-10Independent statistical analysis of Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ORION-2Independent statistical analysis of A Study of ALN-PCSSC in Participants With Homozygous Familial Hypercholesterolemia (HoFH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ORION-5Independent statistical analysis of A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ORKAIndependent statistical analysis of Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Orphenadrine and Methocarbamol for LBP: Complete Statistical AnalysisIndependent statistical analysis of Orphenadrine and Methocarbamol for LBP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02665286).
- ORSIndependent statistical analysis of Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ORTIZIndependent statistical analysis of The ORTIZ Study: Optimising RASi Therapy With SZC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04983979).
- orvepitant MDDIndependent statistical analysis of A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder: primary endpoint results, effect estimate with confidence…
- OsaStimB2Independent statistical analysis of DAW1033B2 in Obstructive Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03426631).
- OSDIIndependent statistical analysis of Oral Sedation During Cervical Dilator Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03202550).
- Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza: Complete Statistical AnalysisIndependent statistical analysis of Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer: Complete Statistical AnalysisIndependent statistical analysis of OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00076310).
- Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation: Complete Statistical AnalysisIndependent statistical analysis of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03414814).
- Osimertinib Study in Indian Patients: Complete Statistical AnalysisIndependent statistical analysis of Osimertinib Study in Indian Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03853551).
- OSKIRA – 3Independent statistical analysis of Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to…
- OSKIRA-Asia-1Independent statistical analysis of Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- OSLER-2Independent statistical analysis of Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OSPREYIndependent statistical analysis of A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OSTEO2Independent statistical analysis of Treatment of Post-Extraction Dehisced Socket - A Case Series Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02980211).
- Osteoarthritis Shoulder Injection Study: Complete Statistical AnalysisIndependent statistical analysis of Osteoarthritis Shoulder Injection Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03586687).
- OSTROIndependent statistical analysis of Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- OSU Plate Waste Study: Complete Statistical AnalysisIndependent statistical analysis of OSU Plate Waste Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02790502).
- OTM-PCORIIndependent statistical analysis of On the Move: Optimizing Participation in Group Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01986647).
- OTO-313 in Subjects With Unilateral Subjective Tinnitus: Complete Statistical AnalysisIndependent statistical analysis of OTO-313 in Subjects With Unilateral Subjective Tinnitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04829214).
- Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift: Complete Statistical AnalysisIndependent statistical analysis of Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01444846).
- OTT15-04Independent statistical analysis of Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the…
- Otteroo Case Series: Complete Statistical AnalysisIndependent statistical analysis of Otteroo Case Series: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03502265).
- OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery: primary endpoint results, effect estimate…
- Outcomes for One-stage and Two-stage Brachial Basilic Arteriovenous Fistulas: Complete Statistical AnalysisIndependent statistical analysis of Outcomes for One-stage and Two-stage Brachial Basilic Arteriovenous Fistulas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04376567).
- Outcomes of Anterior Colporrhaphy Versus Graft Reinforced Anterior Prolapse Repair: Complete Statistical AnalysisIndependent statistical analysis of Outcomes of Anterior Colporrhaphy Versus Graft Reinforced Anterior Prolapse Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00535301).
- OutgrowersIndependent statistical analysis of Stimulating Private Sector Malaria Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01397851).
- OUtMATCHIndependent statistical analysis of Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Outpatient Control-to-Range: System and Monitoring Testing: Complete Statistical AnalysisIndependent statistical analysis of Outpatient Control-to-Range: System and Monitoring Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01578980).
- Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction: Complete Statistical AnalysisIndependent statistical analysis of Outpatient Foley Catheter Compared to Usual Inpatient Care for Labor Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OVERIndependent statistical analysis of Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Over Active Bladder Patients Having Sling Surgery: Complete Statistical AnalysisIndependent statistical analysis of Over Active Bladder Patients Having Sling Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00852696).
- Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter’s Syndrome, Refractory CLL and PLL: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter’s Transformation and Leukemias: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418093).
- Oxcarbazepine Versus Placebo in Childhood Autism: Complete Statistical AnalysisIndependent statistical analysis of Oxcarbazepine Versus Placebo in Childhood Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00467753).
- Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…